NMTRQ — 9 Meters Biopharma Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Brief: 9 Meters Biopharma- Agreement With Ebris To Continue Evaluation Of Larazotide For Covid-19 Respiratory Complications
Brief: 9 Meters Biopharma Files Prospectus Supplement Related To Offering Of 46.2 Mln Shares Of Common Stock - SEC Filing
Brief: 9 Meters Biopharma Announces Positive Topline Data For NM-002 In Phase 1B/2A Trial For Short Bowel Syndrome
Brief: 9 Meters Biopharma Announces Positive Preclinical Data For NM-102, A Gut Microbiome Modulator In Immune Checkpoint Inhibitor Failure Model
Brief: 9 Meters Biopharma Reports Q3 Loss Per Share $0.06
Brief: 9 Meters Biopharma Inc Files For Mixed Shelf Of Up To $200 Mln
Brief: 9 Meters Biopharma Inc Posts Quarterly Loss Per Share Of $0.57
Brief: 9 Meters Biopharma - May Offer & Sell Common Stock Having Offering Price Of Upto $40 Million From Time To Time Through Suntrust
Brief: 9 Meters Biopharma Inc Doses First Patients In Phase 1B/2A Clinical Trial In Short Bowel Syndrome
Brief: 9 Meters Biopharma Files Prospectus Relates To Resale From Time To Time By Selling Stockholders Of Up To 84.6 Mln Shares Of Common Stock
NASDAQ RESUMED AT 08:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 08:31 AM
Brief: Innovate Biopharmaceuticals Says Got Complaint Filed In A North Carolina Court, About Vendor Alleging Co Owes About $1.7 Mln For Services Prior To Feb 2019
Brief: Innovate Biopharma Sees RDD Pharma Merger To Close End Of April
Innovate Biopharma: Rises on waiving some deal terms with RDD Pharma
Brief: Innovate Biopharmaceuticals Entered Letter Agreement With RDD Pharma To Waive Certain Terms Of Merger Agreement
Brief: Rdd Pharma To Acquire Naia Rare Diseases
U.S. STOCKS ON THE MOVE-FuelCell Energy, International Seaways, Harley-Davidson
U.S. STOCKS ON THE MOVE-Uber, Akcea Therapeutics, E*Trade Financial, Match Group